Detection of breast cancer micrametastases in peripheral blood using immunomagnetic separation and immunocytochemistry

Breast Cancer

Volumn 8, Issue 1, 2001, Pages 63-69

  Kim, Seung Jin ^a   Ikeda, Noriko ^a   Shiba, Eiichi ^a   Takamura, Yuki ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Immunocytochemistry; Immunomagnetic separation; Micrometastases; Peripheral blood

Indexed keywords

KERATIN; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CANCER STAGING; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOMAGNETIC SEPARATION; LYMPH NODE METASTASIS; METABOLISM; METHODOLOGY; PATHOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR EMBOLISM;

BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOMAGNETIC SEPARATION; KERATINS; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035234605     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967480     Document Type: Article

References (42)

1. Pelkey TJ, Frierson Jr HF, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42:1369-1381, 1996. (Pubitemid 26300233)
2. Funke I, Schraut W: Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16:557-566, 1998. (Pubitemid 28135599)
3. Braun S, Pantel K: Micrometastatic bone marrow involvement: detection and prognostic significance. Medical Oncology 16:154-165, 1999. (Pubitemid 29466091)
4. Cote RJ, Rosen PP, Lesser ML, et al: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991.
5. Pantel K, Schlimok G, Braun S, et al: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424, 1993. (Pubitemid 23264351)
6. Braun S, Muller M, Hepp F, et al: Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status. J Natl Cancer Inst 90:1099-1101, 1998. (Pubitemid 28350276)
7. Braun S, Pantel K, Muller M, et al: Cytokeratin-posirive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525-533, 2000. (Pubitemid 30117892)
8. Mansi JL, Gogas H, Bliss JM, et al: Outcome of primary- breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 354:197-202, 1999. (Pubitemid 29329158)
9. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27:236-239, 1991.
10. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer 27:1552-1555, 1991.
11. Berger U, Bettelheim R, Mansi JL, et al: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90:1-6, 1988.
12. Diel IJ, Kaufmann M, Costa SD, et al: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88:1652-1664, 1996.
13. Solomayer E-F, Diel IJ, Wallwiener D, et al: Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer. Br J Cancer 76:812-818, 1997. (Pubitemid 27379752)
14. Molino A, Pelosi G, Turazza M, et al: Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42:23-30, 1997. (Pubitemid 27056725)
15. Pantel K, Schlimok G, Angstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994.
16. Kruger W, Krzizanowski C, Holweg M, et al: Reverse transcriptase/ polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122:679-686, 1996. (Pubitemid 26349022)
17. Bostick PJ, Chatterjee S, Chi DD, et al: Limitation of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640, 1998. (Pubitemid 28363026)
18. Schoenfeld A, Kruger KH, Gomm J, et al: The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33:854-861, 1997. (Pubitemid 27287035)
19. Vannucchi AM, Bosi A, Glinz S, et al: Evaluation of breast tumor cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin- 19 mRNA. BrJHaemat 103:610-617, 1998. (Pubitemid 28545293)
20. Slade MJ, Smith BM, Sinnett HD, et al: Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol17:870-879, 1999. (Pubitemid 29109317)
21. Gerhard M, Juhl H, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.J Clin Oncol 12:725-729, 1994. (Pubitemid 24110911)
22. Ghossein RA, Bhattacharya S, Rosai J: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5: 1950-1960, 1999. (Pubitemid 29399243)
23. Raj GV, Moreno JG, Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82:1419-1442, 1998. (Pubitemid 28164986)
24. Janni W, Gastroph S, Hepp F, et al: Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma. Cancer 88:2252-2259, 2000. (Pubitemid 30247124)
25. Hermanek P: Disseminated tumor cells versus micrometastasis: definitions and problems. Anticancer Res 19:2771-2777, 1999.
26. Naume B, Borgen E, Beiske K, et al: Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.JHematother 6:103-114, 1997.
27. Kremens B, Wieland R, Reuss R: Enrichment of residual tumor cells in bone marrow or peripheral blood cells in a neuroectodermal tumor model. Pediatr Hematol Oncol 11:625-631, 1994. (Pubitemid 24361470)
28. Griwatz C, Brandt B, Assmann G, et al: An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods 183:251-265, 1995.
29. Soria JC, Gauthier LR, Raymond E, et al: Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 5:971-975, 1999. (Pubitemid 29233209)
30. Zhong XY, Kaul S, Lin YS, et al: Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of 30 tumor cells in combination with reverse transcriptase/ polymerase chain reaction for cytokeratin-19. J Cancer Res Clin Oncol 126:212-218, 2000. (Pubitemid 30183024)
31. Watne AL, Sandberg AA, Moore GE: The prognostic value of tumor cells in the blood. Arch Surg 83:190-195, 1961.
32. Engell HC: Cancer cells in the blood. A five to nine year follow up study. Ann Surg 149:457-461, 1959.
33. Landell NE, Silvan A, Zajicek J: Atypical cells in peripheral blood in 100 cases of mammary carcinoma and 100 controls. Acta Cytol 7:91-96, 1963.
34. Moore GE, Sandberg AA: Clinical aspects of cancer cells in the blood. Acta Cytol 9:175-184, 1957.
35. Fleming JA: Tumor cells in the blood in carcinoma of the breast. Proc Roy Soc Med 56:497-500, 1963.
36. Smith BM, Slade MJ, English J, et al: Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol18:1432-1439, 2000. (Pubitemid 30205388)
37. Datta HY, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994. (Pubitemid 24079887)
38. Mori M, Mimori K, Ueo H, et al: Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68:739-743, 1996. (Pubitemid 27062033)
39. Brandt B, Roetger A, Heidl S: Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Int J Cancer 76:824-828, 1998. (Pubitemid 28262100)
40. Singletary SE, Larry L, Trucker SL, et al: Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol47:32-36, 1991.
41. Schlimok G, Pantel K, Loibner H, et al: Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 31A:1799-1803, 1995.
42. Allgayer H, Heiss MM, Riesenberg R, et al: Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 57:1394-1399, 1997. (Pubitemid 27152567)